MBRX
Moleculin Biotech, Inc.
+0.01 (+1.53%)0.75USD135K成交股數14.6M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.5M | 5.4M | 5.1M | 3.7M | 3.6M | 3.4M | 4.9M | 4.1M | 4.3M | 6.6M | 3.3M | 3.9M |
| 銷售管理費用 | 2.1M | 2.5M | 2.4M | 2.1M | 2.1M | 2.5M | 2.2M | 2.1M | 2.4M | 2.3M | 2.6M | 2.5M |
| 營業利益 | −7.6M+32% | −7.9M+32% | −7.5M+6% | −5.9M-5% | −5.7M-14% | −5.9M-33% | −7.1M+20% | −6.2M-4% | −6.7M | −8.9M | −5.9M | −6.4M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −7.6M-57% | −12.8M+118% | 82.7M-1277% | −25.4M+322% | −17.8M+177% | −5.9M-112% | −7.0M+25% | −6.0M+1% | −6.4M | 49.3M | −5.6M | −6.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.3M | 10.3M | 8.9M | 6.7M | 7.6M | 7.7M | 9.4M | 10.8M | 16.8M | 23.6M | 24.6M | 32.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 21.1M | 23.4M | 22.1M | 20.4M | 21.6M | 21.0M | 23.4M | 25.6M | 30.8M | 38.2M | 39.5M | 47.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 9.5M | 8.2M | 7.1M | 47.3M | 25.2M | 7.2M | 15.9M | 7.9M | 9.3M | 12.1M | 4.4M | 6.8M |
| 股東權益 | 11.6M | 15.2M | 15.0M | −26.9M | −4K | 13.8M | 17.4M | 19.4M | 25.0M | 30.9M | 35.1M | 40.3M |
| 負債比 | 45.1% | 35.0% | 32.2% | 232.3% | 116.6% | 34.4% | 68.0% | 30.8% | 30.0% | 31.8% | 11.1% | 14.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −6.1M+34% | – | – | – | −4.6M | – | – | −6.7M | – | – | – |
| 資本支出 | – | – | – | – | – | 0.00 | – | – | 0.00 | – | – | – |
| 自由現金流 | – | – | – | – | – | −4.6M | – | – | −6.7M | – | – | – |
| 折舊攤銷 | 8K | 8K | 9K | 21K | 29K | 31K | 31K | 31K | 32K | 34K | 32K | 31K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | 33.6M | –% | – | −22.7M |
| FY2024 | 0.00 | – | 26.0M | –% | – | −23.9M |
| FY2023 | 0.00 | – | 29.8M | –% | – | −23.7M |
| FY2022 | 0.00 | – | −29.0M | –% | – | −27.7M |
| FY2021 | 0.00 | – | −15.9M | –% | -0.59 | −19.0M |
| FY2020 | 0.00 | – | −17.4M | –% | -1.76 | −18.1M |
| FY2019 | 0.00 | – | −13.2M | –% | -1.95 | −17.3M |
| FY2018 | 0.00 | – | −11.9M | –% | -0.46 | −12.6M |